Headache severity in patients with post COVID-19 condition: a case-control study.
Headache
Long COVID
Post COVID
Post COVID-19 condition
Post COVID-19 syndrome
Quality of life
Journal
European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030
Informations de publication
Date de publication:
25 Jun 2024
25 Jun 2024
Historique:
received:
04
04
2024
accepted:
17
06
2024
medline:
25
6
2024
pubmed:
25
6
2024
entrez:
24
6
2024
Statut:
aheadofprint
Résumé
Post COVID-19 conditions (PCC) present with a wide range of symptoms. Headache is one of the most frequently reported neurological symptoms by patients with PCC. We aimed to assess the prevalence of headache in patients with PCC who attended the Post-COVID
Identifiants
pubmed: 38914852
doi: 10.1007/s00406-024-01850-8
pii: 10.1007/s00406-024-01850-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Augustin M, Schommers P, Stecher M et al (2021) Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health – Europe. https://doi.org/10.1016/j.lanepe.2021.100122
doi: 10.1016/j.lanepe.2021.100122
pubmed: 34308410
Sudre CH, Murray B, Varsavsky T et al (2021) Attributes and predictors of long COVID. Nat Med 27:626–631
doi: 10.1038/s41591-021-01292-y
pubmed: 33692530
pmcid: 7611399
Nalbandian A, Sehgal K, Gupta A et al (2021) Post-acute COVID-19 syndrome. Nat Med 27:601–615
doi: 10.1038/s41591-021-01283-z
pubmed: 33753937
pmcid: 8893149
Hallek M, Adorjan K, Behrends U, Ertl G, Suttorp N, Lehmann C (2023) Post-COVID syndrome. Dtsch Arztebl Int 120:48–55
pubmed: 36633452
pmcid: 10060997
Garg M, Maralakunte M, Garg S et al (2021) The Conundrum of Long-COVID-19: a narrative review. Int J Gen Med 14:2491–2506
doi: 10.2147/IJGM.S316708
pubmed: 34163217
pmcid: 8214209
Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, Patel U (2022) Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)—A systematic review and meta-analysis. J Med Virol 94:253–262
doi: 10.1002/jmv.27309
pubmed: 34463956
Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition . Accessed 6 Jul 2023
(2020) Healthcare Workers. In: Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html . Accessed 10 Jul 2023
Stefanou M-I, Palaiodimou L, Bakola E et al (2022) Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis 13:20406223221076890
doi: 10.1177/20406223221076890
pubmed: 35198136
pmcid: 8859684
Severo Bem Junior L, Do Rego Aquino PL, Nunes Rabelo N, Do Rego Aquino MA, Veiga Silva AC, Ferreira Valenca Mota RDC, Rocha Cirne De Azevedo Filho H (2020) SARS-CoV-2 and Nervous System - neurological manifestations in patients with COVID-19: a systematic review. J Neurol Res 10:113–121
doi: 10.14740/jnr602
pubmed: 33984094
pmcid: 8040459
Carfì A, Bernabei R, Landi F, Gemelli Against, COVID-19 Post-Acute Care Study Group (2020) Persistent symptoms in patients after Acute COVID-19. JAMA 324:603–605
doi: 10.1001/jama.2020.12603
pubmed: 32644129
pmcid: 7349096
Beghi E, Giussani G, Westenberg E et al (2022) Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J Neurol 269:2265–2274
doi: 10.1007/s00415-021-10848-4
pubmed: 34674005
Tana C, Bentivegna E, Cho S-J et al (2022) Long COVID headache. J Headache Pain 23:93
doi: 10.1186/s10194-022-01450-8
pubmed: 35915417
pmcid: 9340759
(2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1–211
Chhabra N, Grill MF, Singh RBH (2022) Post-COVID headache: a Literature Review. Curr Pain Headache Rep 26:835–842
doi: 10.1007/s11916-022-01086-y
pubmed: 36197571
pmcid: 9533267
Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, Suen J, Robba C, Fraser J, Cho S-M (2022) Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci 434:120162
doi: 10.1016/j.jns.2022.120162
pubmed: 35121209
pmcid: 8798975
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv 2021.01.27.21250617
Fernández-de-las-Peñas C, Navarro-Santana M, Gómez-Mayordomo V, Cuadrado ML, García-Azorín D, Arendt-Nielsen L, Plaza-Manzano G (2021) Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol 28:3820–3825
doi: 10.1111/ene.15040
pubmed: 34327787
pmcid: 8444899
Rodrigues AN, Dias ARN, Paranhos ACM, Silva CC, Bastos T da, de Brito R, da Silva BB, de Sousa NM, de Quaresma E, Falcão JAS (2023) LFM Headache in long COVID as disabling condition: A clinical approach. Front Neurol 14:1149294
Franke C, Berlit P, Prüss H (2022) Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology. Neurol Res Pract 4:28
doi: 10.1186/s42466-022-00191-y
pubmed: 35843984
pmcid: 9288923
Fernández-de-Las-Peñas C, Cuadrado ML, Gómez-Mayordomo V, García-Azorín D, Arendt-Nielsen L (2023) Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 variant. Expert Rev Neurother 23:179–186
doi: 10.1080/14737175.2023.2185138
pubmed: 36857191
Aiyegbusi OL, Hughes SE, Turner G et al (2021) Symptoms, complications and management of long COVID: a review. J R Soc Med 114:428–442
doi: 10.1177/01410768211032850
pubmed: 34265229
pmcid: 8450986
Gómez-Dabó L, Melgarejo-Martínez L, Caronna E, Pozo-Rosich P (2023) Headache in COVID-19 and Long COVID: to know facts for clinical practice. Curr Neurol Neurosci Rep 23:551–560
doi: 10.1007/s11910-023-01296-w
pubmed: 37665495
Lippi G, Sanchis-Gomar F, Henry BM (2023) COVID-19 and its long-term sequelae: what do we know in 2023? Pol Arch Intern Med 133:16402
pubmed: 36626183
Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ (2022) Neurological sequelae of COVID-19. J Integr Neurosci 21:77
doi: 10.31083/j.jin2103077
pubmed: 35633158
Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, Pardo CA, Choi A, Cho S-M (2023) Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells 12:816
doi: 10.3390/cells12050816
pubmed: 36899952
pmcid: 10001044
Files JK, Sarkar S, Fram TR et al Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses. JCI Insight 6:e151544
Tana C, Giamberardino MA, Martelletti P (2023) Long COVID and especially headache syndromes. Curr Opin Neurol 36:168
doi: 10.1097/WCO.0000000000001153
pubmed: 37078648
Trigo J, García-Azorín D, Sierra-Mencía Á, Tamayo-Velasco Á, Martínez-Paz P, Tamayo E, Guerrero AL, Gonzalo-Benito H (2021) Cytokine and interleukin profile in patients with headache and COVID-19: a pilot, CASE-control, study on 104 patients. J Headache Pain 22:51
doi: 10.1186/s10194-021-01268-w
pubmed: 34088273
pmcid: 8177251
Adorjan K, Heindl B, Stubbe HC (2022) Post-COVIDLMU: Implementierung Und Evaluierung eines interdisziplinären und sektorenübergreifenden versorgungs- und Forschungsnetzwerks für eine evidenzgeleitete Behandlung Von Patienten Mit Schwerem Post-COVID-Syndrom. Nervenarzt 93:797–803
doi: 10.1007/s00115-022-01322-1
pubmed: 35695907
pmcid: 9190193
Adorjan K, Ruzicka M, Ibarra G, Stubbe HC (2023) Behandlung Des Schweren Post-covid-syndroms. MMW Fortschr Med 165:52–57
doi: 10.1007/s15006-022-2187-y
pubmed: 36648675
pmcid: 9844173
WHOQOL - Measuring Quality of Life| The World Health Organization https://www.who.int/tools/whoqol . Accessed 17 Jul 2023
WHOQOL-BREF| The World Health Organization https://www.who.int/tools/whoqol/whoqol-bref . Accessed 17 Jul 2023
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613
doi: 10.1046/j.1525-1497.2001.016009606.x
pubmed: 11556941
pmcid: 1495268
Costantini L, Pasquarella C, Odone A et al (2021) Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): a systematic review. J Affect Disord 279:473–483
doi: 10.1016/j.jad.2020.09.131
pubmed: 33126078
Machado MO, Kang N-YC, Tai F, Sambhi RDS, Berk M, Carvalho AF, Chada LP, Merola JF, Piguet V, Alavi A (2021) Measuring fatigue: a meta-review. Int J Dermatol 60:1053–1069
doi: 10.1111/ijd.15341
pubmed: 33301180
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123
doi: 10.1001/archneur.1989.00520460115022
pubmed: 2803071
Hawthorne G, Herrman H, Murphy B (2006) Interpreting the WHOQOL-Brèf: preliminary Population norms and effect sizes. Soc Indic Res 77:37–59
doi: 10.1007/s11205-005-5552-1
Straube A, Aicher B, Förderreuther S, Eggert T, Köppel J, Möller S, Schneider R, Haag G (2013) Period prevalence of self-reported headache in the general population in Germany from 1995–2005 and 2009: results from annual nationwide population-based cross-sectional surveys. J Headache Pain 14:11
doi: 10.1186/1129-2377-14-11
pubmed: 23565641
pmcid: 3620427
Straube A, Ruscheweyh R (2019) Epidemiologie Von Kopfschmerzen über die Lebensspanne. Nervenheilkunde 38:735–739
doi: 10.1055/a-0988-4322
Radtke A, Neuhauser H (2009) Prevalence and burden of headache and migraine in Germany. Headache 49:79–89
doi: 10.1111/j.1526-4610.2008.01263.x
pubmed: 19125877
Lipton RB, Pozo-Rosich P, Orr SL, Reed ML, Fanning KM, Dabruzzo B, Buse DC (2023) Impact of monthly headache days on migraine‐related quality of life: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 63:1448–1457
doi: 10.1111/head.14629
pubmed: 37795746
Mutiawati E, Kusuma HI, Fahriani M, Harapan H, Syahrul S, Musadir N (2022) Headache in Post-COVID-19 patients: its characteristics and relationship with the quality of life. Med (Kaunas) 58:1500
Fujita K, Otsuka Y, Sunada N, Honda H, Tokumasu K, Nakano Y, Sakurada Y, Obika M, Hagiya H, Otsuka F (2023) Manifestation of Headache affecting Quality of Life in Long COVID patients. J Clin Med 12:3533
doi: 10.3390/jcm12103533
pubmed: 37240639
pmcid: 10219375
Förster C, Colombo MG, Wetzel A-J, Martus P, Joos S (2022) Persisting symptoms after COVID-19. Dtsch Arztebl Int 119:167–174
pubmed: 35236547
pmcid: 9215272
Tabacof L, Tosto-Mancuso J, Wood J et al (2022) Post-acute COVID-19 Syndrome negatively impacts physical function, cognitive function, Health-Related Quality of Life, and participation. Am J Phys Med Rehabil 101:48–52
doi: 10.1097/PHM.0000000000001910
pubmed: 34686631
Yong SJ (2021) Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis 53:737–754
doi: 10.1080/23744235.2021.1924397
Coughlin SS (1990) Recall bias in epidemiologic studies. J Clin Epidemiol 43:87–91
doi: 10.1016/0895-4356(90)90060-3
pubmed: 2319285